Violette Shelia M. 4

4 · Q32 Bio Inc. · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 28, 2026

Q32 Bio (QTTB) CSO Shelia M. Violette Sells 2,815 Shares

What Happened

Shelia M. Violette, Chief Scientific Officer of Q32 Bio (QTTB), reported a sale of 2,815 shares on 2026-02-25. The weighted average sale price was $4.51 per share, resulting in proceeds of approximately $12,708. This sale was to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs), not an independent discretionary sale.

Key Details

Transaction date: 2026-02-25; filing date (Form 4): 2026-02-27 (appears timely — within typical two-business-day reporting window).
Transaction type: Sale (S); reason: automatic sale to cover tax withholding for RSU vesting (see footnote F1).
Price: weighted average $4.51; individual sale prices ranged from $4.35 to $4.69 (footnote F2).
Proceeds: ~$12,708.
Shares after transaction: not specified in the provided data; reported holdings are held by Violette Holdings LLC. The reporting person is a manager of Violette Holdings and disclaims beneficial ownership except for any pecuniary interest (footnote F3).
Footnotes: F1 = automatic sale for tax withholding; F2 = weighted-average price with range and offer to provide per-price details on request; F3 = shares held by Violette Holdings, with disclaimer of beneficial ownership.

Context

This was a tax-withholding sale related to RSU vesting (routine administrative transaction). Such sales are common and do not necessarily signal the insider’s view on the company. The filing shows multiple executions at slightly different prices within the $4.35–$4.69 range, aggregated to the reported weighted average.

Form 4

Period: 2026-02-25

Chief Scientific Officer

Transactions

Holdings

Footnotes (3)

[F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.35 to $4.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
[F3]Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.

Signature

/s/ Eric Bell, Attorney-in-Fact|2026-02-27

1 file